Home › Clinical Trials › Cancer Clinical Trial › Hodgkin s Lymphoma Leukemia other Lymphoid Leukemia Multiple Myeloma Myeloid and Monocytic Leukemia › A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study of a Non-Covalent, Reversible Bruton's Tyrosine Kinase Inhibitor, SNS 062, in Patients With B-Lymphoid Malignancies